Targeted & controlled bone healing
  • slidebg1
  • slidebg1
  • slidebg1
Kuros has spent more than a decade refining technologies that instruct the body to form bone using targeted and controlled mechanisms of action.

Kuros Biosciences are experts in the science of orthobiologics.

Our technology platforms aim to deliver improved patient outcomes through targeted and controlled bone healing.

We are poised to realise this aim through the launch of MagnetOs, based on our flagship surface science technology, and through the expansion of our portfolio by the continued clinical development of products based on our novel TG Hook technology.

Latest News
13 Mar 19
Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
510(k) clearance of the TLIF cage is an important step towards progression of Fibrin-PTH product candidate KUR-113 into clinical development . Kuro ’s TLIF cage will be used in combination with its Fibrin-PTH product candidate in the upcoming interbody spinal fusion clinical trial . READ MORE


11 Feb 19
Kuros Biosciences signs agreement to supply SeaSpine with bone graft incorporating Kuros’s advanced submicron surface technology
Global partner to market an advanced bone graft supplied by Kuros . Agreement demonstrates interest of major orthobiologic companies in Kuros technologies . READ MORE


Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 44 733 47 47   Fax: +41 44 733 47 40   Email: info@kurosbio.com

About Kuros

  1. Overview
  2. Executive Committee
  3. Board
  4. Careers

Products

  1. MagnetOs

Pipeline

  1. Pipeline
  2. Spinal fusion
    KUR-113
  3. Fracture repair
    KUR-111
    KUR-113
  4. Surgical Sealants
    Neuroseal (KUR-023)

Technologies

  1. Surface Science Technology
  2. Fibrin-Based
  3. Synthetic Cross-Linking Technology
  4. Immune Modulation

Partnerships

  1. Collaborations
  2. Business Development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & Presentations
  4. Analysts
  5. Calendar
  6. Corporate governance
  7. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Kuros has spent more than a decade refining technologies that instruct the body to form bone using targeted and controlled mechanisms of action.

Kuros Biosciences are experts in the science of orthobiologics.

Our technology platforms aim to deliver improved patient outcomes through targeted and controlled bone healing.

We are poised to realise this aim through the launch of MagnetOs, based on our flagship surface science technology, and through the expansion of our portfolio by the continued clinical development of products based on our novel TG Hook technology.

Latest News
13 Mar 19
Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
510(k) clearance of the TLIF cage is an important step towards progression of Fibrin-PTH product candidate KUR-113 into clinical development . Kuro ’s TLIF cage will be used in combination with its Fibrin-PTH product candidate in the upcoming interbody spinal fusion clinical trial . READ MORE


11 Feb 19
Kuros Biosciences signs agreement to supply SeaSpine with bone graft incorporating Kuros’s advanced submicron surface technology
Global partner to market an advanced bone graft supplied by Kuros . Agreement demonstrates interest of major orthobiologic companies in Kuros technologies . READ MORE